Verano Holdings (VRNO) Change in Receivables (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Change in Receivables of $1.7 million for Q1 2026, little changed year-over-year from $1.7 million in Q1 2025, and up 226.99% quarter-over-quarter from -$1.3 million in Q4 2025.
Verano Holdings (VRNO) Change in Receivables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Change in Receivables for 6 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables changed 0.41% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at -$5.3 million (down 541.98% YoY), while the FY2025 annual figure was -$5.4 million, down 295.01% from the prior year.
- Change in Receivables grew to $1.7 million in Q1 2026 per VRNO's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.6 million in Q2 2023 and bottomed at -$7.7 million in Q2 2025.
- Historically, Change in Receivables has averaged $1.2 million across 5 years, with a median of $1.7 million in 2026.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 520.82% — and 2025, when it tumbled 522.33%.
- Verano Holdings' Change in Receivables stood at $1.2 million in 2022, then soared by 351.58% to $5.6 million in 2023, then sank by 199.18% to -$5.5 million in 2024, then jumped by 75.75% to -$1.3 million in 2025, then soared by 226.99% to $1.7 million in 2026.
- Business Quant data shows VRNO's Change in Receivables at $1.7 million in Q1 2026, -$1.3 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn | -2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.27 Mn |
| Jun 30, 2026 | -2.27 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Dec 31, 2025 | -1.34 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | -7.72 Mn |
| Jun 30, 2025 | -7.72 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Mar 31, 2024 | 3.23 Mn |